The bottom line: Based upon the data, Cellceutix has decided that a pivotal Phase 3 trial in 2015 will be for a single-dose of Brilacidin for ABSSSI. -BigKahuna
Everyone on this board that was encouraged by BigKahuna owes him a debt of gratitude.
THANK YOU BigKahuna!
"Games are won by players who focus on the playing field -- not by those whose eyes are glued to the scoreboard." - Warren Buffett